SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-215003
Filing Date
2022-08-08
Accepted
2022-08-08 17:05:05
Documents
14
Period of Report
2022-08-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d388777d8k.htm   iXBRL 8-K 30814
2 EX-99.1 d388777dex991.htm EX-99.1 8059
6 GRAPHIC g388777dsp6.jpg GRAPHIC 4072
  Complete submission text file 0001193125-22-215003.txt   171589

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA rxst-20220808.xsd EX-101.SCH 2845
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE rxst-20220808_lab.xml EX-101.LAB 17979
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rxst-20220808_pre.xml EX-101.PRE 11251
8 EXTRACTED XBRL INSTANCE DOCUMENT d388777d8k_htm.xml XML 3330
Mailing Address 100 COLUMBIA STREET SUITE 120 ALISO VIEJO CA 92656
Business Address 100 COLUMBIA STREET SUITE 120 ALISO VIEJO CA 92656 949-521-7822
RxSight, Inc. (Filer) CIK: 0001111485 (see all company filings)

IRS No.: 943268801 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40690 | Film No.: 221145289
SIC: 3851 Ophthalmic Goods
Industrial Applications and Services